LLY - Reassessing Amphastar Pharmaceuticals
2024-05-15 10:11:37 ET
Summary
- Amphastar Pharmaceuticals, Inc. stock is down approximately 30% this year, and the company reported mixed Q1 results last week.
- Despite the poor performance of the stock so far in 2024, there are some positives on the company and its stock.
- An updated analysis around Amphastar Pharmaceuticals follows in the paragraphs below.
Today, we take our first look at Amphastar Pharmaceuticals, Inc. ( AMPH ) in 2024. The stock of this biopharma concern is down some 30% year to date, and the company reported mixed Q1 results last week. Where do the shares go from here? An updated analysis follows below....
Reassessing Amphastar Pharmaceuticals